InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Spaventa Andrew, Chief Executive Officer. Director active across 1 company, notably Singular Genomics Systems, Inc.. In total, 18 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €16k. History available since 16 November 2023. The latest transaction was filed on 16 November 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
325 sharesCommon StockSEC:0000950170-25-027112:0
1,907 sharesCommon StockSEC:0000950170-25-021402:0
486 sharesCommon StockSEC:0000950170-24-137425:0
1,907 sharesCommon StockSEC:0000950170-24-126428:0
487 sharesCommon StockSEC:0000950170-24-107502:0
1,906 sharesCommon StockSEC:0000950170-24-097190:0
14,584 sharesCommon StockSEC:0000950170-24-075034:0
57,188 sharesCommon StockSEC:0000950170-24-058955:0
14,583 sharesCommon StockSEC:0001209191-24-004948:0
14,583 sharesCommon StockSEC:0001209191-23-059005:0
43,468 shares@ US$0.4108100.0% of flowCommon StockSEC:0001209191-23-056071:0
Ideal exit: 12 Aug 2024 (T+270)
14,584 sharesCommon StockSEC:0001209191-23-049652:0
14,583 sharesCommon StockSEC:0001209191-23-038481:0
173,144 sharesCommon StockSEC:0001209191-22-021034:0
715,884 sharesCommon StockSEC:0001209191-21-068185
715,884 sharesCommon StockSEC:0001209191-21-068185:0
715,884 sharesCommon StockSEC:0001209191-21-037022:0
715,884 sharesCommon StockSEC:0001209191-21-037022
18 of 18 declarations
About Spaventa Andrew
Andrew Spaventa is the Chief Executive Officer of Singular Genomics Systems, Inc. In this role, he oversees the company's operations and is responsible for implementing the business strategy. Andrew brings significant expertise in the biotechnology sector, contributing to innovation and growth within the company. His leadership is essential for guiding Singular Genomics to new heights.
